Clinical Trial Update: Effect of Selective COX-2 Inhibition on Ulcer Healing [Phase 3]

View source ↗

Summary

Phase 3 trial investigating the effect of selective COX-2 inhibition on ulcer healing has completed, in patients with arthritis and gastric ulcers.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Arthritis
• Gastric Ulcer

Drugs mentioned

• COX-2 selective inhibitor (unspecified)

Snippet

Sponsor: Chinese University of Hong Kong | Conditions: Arthritis, Gastric Ulcer | Phase 3 | Status: COMPLETED